Navigation Links
Holiday Gift From Big Pharma

Mondays Wall Street Journal featured the news of pharmaceutical giant Pfizer acquiring Midwest biotech company Esperion Therapeutics for $1.3 billion.

Esperion, which is based in Ann Arbor, Mich., develops cardiovascular medicine that may be useful for the treatment of the heart disease atherosclerosis. Remember that Pfizer has......

Full article >>> om/" target="blank">Genitope (cancer vaccines) are trading below the initial IPO price. As a group, the first seven are down 16 percent since their offerings.

Eyetech Pharmaceuticals was queued up for close to a $150 million IPO. Though Eyetech has a deal with Pfizer valued up to $745 million for its macular degeneration product......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 12/22/03


Related biology technology :

1. Unwrapping Political Perks for the Holidays
2. Holiday Tech Gizmos to Give and Get
3. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
4. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
5. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
6. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. The deconstruction of Big Pharma
9. First half of 2006 roundup: Big Pharma trumps biotech
10. Big Pharmas continued hunger and search for new products
11. Leading global Big Pharma companies of 2005
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... manufacturing company, today announced several positive developments that position the Company for the ... result of the transaction, Craig F. Kinghorn has been appointed Chairman of the ...
(Date:5/25/2016)... ... 2016 , ... Founder of the Fitzmaurice Hand Institute in ... of the hand by the National Board of Physicians and Surgeons, as of ... in his pursuit of providing the most comprehensive, effective treatment for his patients, ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. ... the company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar ... FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is ...
(Date:5/23/2016)... ... ... need for blood donations in South Texas and across the nation is growing. , But ... blood donations are on the decline. In fact, donations across the country are at their ... Texas in the last four years alone. , There is no substitute for blood. , ...
Breaking Biology Technology:
(Date:3/21/2016)... -- Unique technology combines v ...   Xura, Inc. (NASDAQ: ... communications services, today announced it is working alongside SpeechPro ... particularly those in the Financial Services Sector, the ability ... a mobile app, alongside, and in combination with, traditional ...
(Date:3/15/2016)... 15, 2016 Yissum Research Development Company ... company of the Hebrew University, announced today the formation ... technology of various human biological indicators. Neteera Technologies has ... from private investors. ... detection of electromagnetic emissions from sweat ducts, enables reliable ...
(Date:3/11/2016)... , March 11, 2016 ... new market research report "Image Recognition Market by Technology ... (Marketing and Advertising), by Deployment Type (On-Premises and Cloud), ... To 2022", published by MarketsandMarkets, the global market is ... to USD 29.98 Billion by 2020, at a CAGR ...
Breaking Biology News(10 mins):